Positron Emission Tomography Scanners Market Growth Accelerated by Enhanced Cancer Detection Capabilities

 


The positron emission tomography (PET) scanners market involves medical imaging devices used for early and accurate cancer detection. PET scanners produce three-dimensional images of metabolic activities inside the body using radioactive tracers and are extensively used for diagnosing, staging, restaging, and monitoring cancer and other diseases.

The global Positron Emission Tomography Scanners Market is estimated to be valued at US$ 2.5 Bn in 2023 and is expected to exhibit a CAGR of 6.6% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends:

One of the key trends driving the growth of the positron emission tomography (PET) scanners market is enhanced cancer detection capabilities. PET scanners enable precise detection and localization of cancer at the molecular level using targeted radiotracers, which helps in early diagnosis and treatment monitoring. They provide functional information about tumor biology through metabolic imaging that complement structural MRI and CT scans. This enhanced capability to non-invasively track tumor metabolism in real-time allows oncologists to detect cancer recurrence earlier and helps guide targeted therapy. With rising cancer prevalence globally, demand for more sensitive diagnostic tools is increasing, thus fueling the adoption of PET scanners in clinical settings.

Segment Analysis
The global positron emission tomography scanners market is dominated by the hybrid PET scanners segment owing to its advantages over standalone PET scanners such as simultaneous anatomical and functional imaging capabilities. Hybrid PET scanners provide images of metabolic activity along with the anatomical details, which helps physicians obtain a comprehensive view of the disease state. Hence, hybrid PET scanners have higher adoption rates among end users.

Key Takeaways
The global positron emission tomography scanners market is expected to witness high growth over the forecast period of 2023 to 2030.

Regional analysis: North America dominated the market and is expected to continue its dominance over the forecast period. Factors such as increasing incidence of cancer and cardiac disorders, supportive reimbursement policies, and significant healthcare expenditure drive the growth of positron emission tomography scanners market in the region.

Key players operating in the positron emission tomography scanners market are Positron Corporation, CellSight Technologies, RefleXion, Clarity Pharmaceuticals, PETsys Electronics SA, Blue Earth Diagnostics Limited, Qubiotech Health Intelligence S.L., Advanced Accelerator Applications, Lily, Agfa-Gevaert Group, CMR Naviscan, Neusoft Corporation, Siemens, Segamicorp, ONCOVISION, MedX Holdings, Inc., Modus Medical Devices Inc., Radiology Oncology Systems, TOSHIBA CORPORATION, and General Electric Company.

Comments

Popular posts from this blog

Neuroendocrine Cancer is the fastest growing segment fueling the growth of Pituitary Cancer Market

Enhancing Patient Care and Comfort: The Evolution of Hospital Beds

Dry Eye Disease Market is Estimated to Witness High Growth Owing to Rising Awareness About Disease Management